Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical breakthrough

NYU AI Predicts 5-Year Breast Cancer Risk

Analysis based on 6 articles · First reported Sep 10, 2026 · Last updated Sep 10, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study highlights growing adoption of AI in medical imaging, potentially boosting demand for AI-assisted diagnostic tools and benefiting equipment makers such as Hologic. However, the near-term market impact is limited as the tool remains in research stages and requires further validation across other health centers and manufacturers.

healthcare medical devices artificial intelligence

Researchers at NYU Langone Health and its Perlmutter Cancer Center developed a deep-learning tool, NYU-DRP, that analyzes a woman's past and recent annual 3D mammograms (longitudinal digital breast tomosynthesis) to predict five-year breast cancer risk. The study, published in the American Journal of Roentgenology, found NYU-DRP correctly ranked higher-risk women 72 percent of the time, versus 70 percent for single 3D mammography and 68 percent for AI-assisted 2D testing. Against the widely used Tyrer-Cuzick risk assessment, NYU-DRP predicted five-year risk correctly 67 percent of the time versus 56 percent. The model was built from 313,531 yearly 3D mammograms from 161,165 women tested at NYU Langone hospitals between 2016 and 2020. The study also found breast density alone did not correspond to predicted risk. All testing used breast imaging equipment manufactured by Hologic. Funding came from the United States — National Science Foundation, the United States — National Institutes of Health, the Milstein Pilot Project Fund, the Shifrin-Myers Breast Cancer Discovery Fund, and the Manhasset Women's Coalition Against Breast Cancer. Lead investigator Yanqi Xu and senior investigator Yiqiu Shen, along with co-investigators Laura Heacock, Jungkyu Park, Felicia Pasadyn, Lei Stanley Qi, Alana Lewin, Krzysztof Geras, Linda Moy, and Freya Schnabel, contributed to the research. The team plans to share and cross-check the tool with other academic health centers and different 3D mammogram manufacturers.

priv
Co-developed the AI tool and provided the research infrastructure, strengthening its position in cancer risk prediction.
Importance 80.0 Sentiment 15.0
stock
Its 3D mammography equipment was used exclusively in the study, potentially increasing demand for its imaging systems if the AI tool gains adoption.
Importance 50.0 Sentiment 10.0
per
Lead investigator who developed the AI model and authored the study.
Importance 50.0 Sentiment 5.0
per
Senior investigator who oversaw the research and plans future validation studies.
Importance 50.0 Sentiment 5.0
priv
Published the peer-reviewed study, lending scientific credibility to the findings.
Importance 40.0 Sentiment 5.0
per
Co-investigator who highlighted the potential for tailored screening based on individual risk.
Importance 40.0 Sentiment 5.0
govactor
Provided grant funding for the study, supporting AI research in medical imaging.
Importance 30.0 Sentiment 5.0
govactor
Provided grant funding for the study, supporting AI research in medical imaging.
Importance 30.0 Sentiment 5.0
cnt
The study addresses breast cancer screening in the US, where 1 in 8 women are diagnosed in their lifetime, potentially improving early detection.
Importance 20.0 Sentiment 5.0
per
Study co-investigator contributing to the research.
Importance 20.0 Sentiment 5.0
per
Study co-investigator contributing to the research.
Importance 20.0 Sentiment 5.0
per
Study co-investigator contributing to the research.
Importance 20.0 Sentiment 5.0
per
Study co-investigator contributing to the research.
Importance 20.0 Sentiment 5.0
per
Study co-investigator contributing to the research.
Importance 20.0 Sentiment 5.0
per
Study co-investigator contributing to the research.
Importance 20.0 Sentiment 5.0
+ 1 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.